J. Goldman & CO LP Pfizer Inc Put Options Transaction History

J. Goldman & CO LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $17.6 Million - $20.6 Million	697,500 New	697,500 $19.5 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $2.29 Million - $2.97 Million	87,500 New	87,500 $2.52 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2.09 Million - $2.73 Million	50,000 New	50,000 $2.56 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $2.79 Million - $3.31 Million	60,000 New	60,000 $3.15 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $1.85 Million - $2.3 Million	-40,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.67 Million - $2.48 Million	40,500 New	40,500 $2.39 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $10.6 Million - $13.6 Million	-270,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $9.7 Million - $11 Million	270,000 New	270,000 $10.6 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.